Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
3.57M
-
Shares change
-
+20.1K
-
Total reported value, excl. options
-
$4.87M
-
Value change
-
+$112K
-
Put/Call ratio
-
0.2
-
Number of buys
-
12
-
Number of sells
-
-7
-
Price
-
$1.37
Significant Holders of Protalix BioTherapeutics, Inc. - COM (PLX) as of Q4 2022
34 filings reported holding PLX - Protalix BioTherapeutics, Inc. - COM as of Q4 2022.
Protalix BioTherapeutics, Inc. - COM (PLX) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.57M shares
.
Largest 10 shareholders include HIGHBRIDGE CAPITAL MANAGEMENT LLC (2.41M shares), MEITAV DASH INVESTMENTS LTD (244K shares), RENAISSANCE TECHNOLOGIES LLC (225K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (134K shares), CITADEL ADVISORS LLC (124K shares), BlackRock Inc. (102K shares), JANE STREET GROUP, LLC (92.2K shares), COMMONWEALTH EQUITY SERVICES, LLC (50.1K shares), CIBC WORLD MARKET INC. (36K shares), and IHT Wealth Management, LLC (26.8K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.